Skip to main content
Hematology and Oncology
ALL Specialities
ALL Specialities
/
Hematology and Oncology
Blood & Cancer Podcast
CME
Diseases & Conditions
Nonmalignant Hematologic Disorders
Anemia
Bleeding Disorders
Thrombosis
Breast Cancer
CNS/Brain Cancer
Gastrointestinal Cancer
Genitourinary Cancer
Renal Cell Carcinoma
Gynecologic Cancer
Head & Neck/Thyroid Cancers
Leukemia, Myelodysplasia, Transplantation
ALL
AML
Cellular Therapy
CLL
CML
Myelodysplastic Syndrome
Transplantation
Lung Cancer
Lymphoma & Plasma Cell Disorders
B Cell Lymphoma
Follicular Lymphoma
Hodgkin Lymphoma
Mantle Cell Lymphoma
Multiple Myeloma
Non-Hodgkin Lymphoma
T Cell Lymphomas
Melanoma
Nonmelanoma Skin Cancer
Sarcoma and GIST
COVID-19 Updates
Conference Coverage
Conference Coverage
'New benchmark' set in phase-3 blood cancer study
Publish date:
June 3, 2022
FROM ASCO 2022
A version of this article first appeared on
Medscape.com
.
Pages
« first
1
2
Recommended Reading
COVID-19: Experts hasten to head off mental health crisis
MDedge Hematology and Oncology
FDA okays new CAR T therapy, first for mantle cell lymphoma
MDedge Hematology and Oncology
Hepatitis screening now for all patients with cancer on therapy
MDedge Hematology and Oncology
Survey quantifies COVID-19’s impact on oncology
MDedge Hematology and Oncology
New inhibitor shows promise in previously failed B-cell malignancies
MDedge Hematology and Oncology
Don’t delay: Cancer patients need both doses of COVID vaccine
MDedge Hematology and Oncology
ZUMA-2, TRANSCEND data pique interest in earlier CAR T for R/R MCL
MDedge Hematology and Oncology
New trials in lymphoma and MM: Could your patient benefit?
MDedge Hematology and Oncology
Ex–hospital porter a neglected giant of cancer research
MDedge Hematology and Oncology
Third-generation Black woman physician makes cancer research history
MDedge Hematology and Oncology
Mantle Cell Lymphoma
Gene Therapy
All Specialties
